High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsElena Yeregui, Anna Rull, Vicenç Falcó et al.|EBioMedicine|2020Cited by 30
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)Daniel Podzamczer, Santiago Moreno, Rafael Micán et al.|Open Forum Infectious Diseases|2021Cited by 7
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched AnalysisDaniel K. Nomah, José M Miró, Yesika Díaz et al.|Open Forum Infectious Diseases|2024Cited by 3
High Circulating SDF-1 and MCP-1 Levels and Genetic Variations in CXCL12, CCL2 and CCR5: Prognostic Signature of Immune Recovery Status in Treated HIV-Infected PatientsElena Yeregui, Anna Rull, Consuelo Viladés et al.|SSRN Electronic Journal|2020Cited by 0
Elucidating the mechanism underlying incomplete immune recovery in people living with HIV through CD4⁺ and CD8⁺ T cell multi-omicsMarina Flores-Piñas, Anna Rull, Sílvia Chafino et al.|Molecular Medicine|2026Cited by 0